You can reach her a lcarr@mjhlifesciences.com.

Lindsey Carr, Associate Editor

The need for a universal endometriosis classification

A literature search revealed there is no international agreement on how to characterize or classify endometriosis.

Treating recurrent vulvovaginal candidiasis with honey

Because the mechanism of action of medical-grade honey (MGH) is based on enhancing wound healing and exerting strong broad-spectrum antimicrobial activity, MGH may also help to treat recurrent vulvovaginal candidiasis (RVVC), according to a review in the 

Microbial interplay of recurrent vulvovaginal candidiasis pathobiology

A clinical study has confirmed that the pathophysiology of recurrent vulvovaginal candidiasis (RVVC) relies primarily on Candida albicans (C. albicans)-specific attributes like hyphal morphogenesis, biofilm formation and pathogenesis that differentiate it from other prominent non-albicans C. (NAC) species.

Patient perspectives on vulvovaginal candidiasis

Among women with vulvovaginal candidiasis (VVC) or recurrent VVC (RVVC), the three 3 most common signs and /symptoms are itching (91.2%), burning (68.3%), and redness (58.1%), according to an online patient survey in 

Articles

Here's what's coming to Contemporary OB/GYN® this week.

This week on Contemporary OB/GYN®: Jan. 17 to Jan. 21

Provider bias in contraceptive counseling

Often based on racial/ethnic, socioeconomic, and age-based assumptions

Mirvie RNA test aims to predict pregnancy complications

Teens in the US lacking quality sex education

Many adolescents across the United States lack quality sex education, a trend that has worsened in recent years. Moreover, national statistics mask significant inequities in the receipt of formal sex education by gender, race and ethnicity, sexual orientation, and the location of instruction, according to a study in the Journal of Adolescent Health.

Female contraception policies at US prisons and jails

Half of prisons and over 80% of jails in the United States allowed postpartum permanent contraception, according to a study in the journal 

Here's what you missed this week from Contemporary OB/GYN®

In case you missed it: Jan. 10 to Jan. 14

Provider bias—stereotyped and prejudiced assumptions about patients and their “best interests”—can limit patient autonomy and informed decision-making, amplify medical distrust, and deter patients from seeking care. Such bias is often amplified when patients are young, low-income, and/or Black, Indigenous, or people of color (BIPOC).

 in family planning can lead providers to: counsel patients inequitably based on demographic characteristics, neglect to assess or respect patients’ contraceptive preferences, encourage, or discourage contraceptive use, and express reluctance or refuse to or remove a LARC method at a patient’s request.

 manifests in patient-provider interactions and influences 

 counseling. Results showed that clinicians often viewed a patient’s race/ethnicity, socioeconomic status, and age as primary challenges when providing contraceptive counseling.

Data were based on individual interviews with 15 clinicians in South Carolina, all of whom worked in ob-gyn and provided LARC methods to Medicaid beneficiaries. The state has a nearly 35% BIPOC population and a poverty rate above the national rate, and 20% of residents are insured through Medicaid.

The interviews explored clinicians’ demographic backgrounds, medical training, current positions, patient population(s), opinions on LARC methods, and contraceptive counseling approaches. All 15 participants identified as cisgender and White/Caucasian, including 1 man and 14 women. Eleven were physicians and 4 were nurses—3 nurse practitioners and 1 registered nurse. Of all participants, 3 were residents and the remaining 12 had 5 or more years of post-residency experience. Eight participants were 40 or older, 5 were in their early 30s, and 2 were in their late 20s.

When asked about working with diverse patient populations, many clinicians referred to “cultural differences” as a primary challenge. They also illustrated difficulty in providing contraceptive counseling to adolescents and patients with negative attitudes or resistance to LARC use.

In 2 cases, clinicians ascribed their difficulties to patients’ race/ethnicity, with 1 nurse saying, “They just don’t want to listen.”

Another clinician cited patients’ low socioeconomic status as the reason for nonadherence to LARC, “My patients with less education and lower socioeconomic status can just be challenging in a way that it’s more difficult for them to be adherent.”

In their frustration with patients’ “culture,” ambivalence, distrust in their medical expertise, lack of self-efficacy and contraceptive adherence, clinicians implied that, unlike their patients, they know what is best.

The interviewer asked participants to describe a typical contraceptive-related conversation and include recent examples, to which clinicians often responded by sharing interactions with adolescent patients. In 1 response, a patient expressed concern after seeing a YouTube video about a local girl whose IUD was misplaced and dislodged, eventually going through her cervix and uterus, causing sepsis and ICU admission, where she ultimately underwent amputation. The respondent said, “17-year-old African American female, of course. Nothing ever happens exactly like that.” This statement implies that young BIPOC patients are uniquely susceptible to implausible scenarios and serious complications.

Another clinician referred to her adolescent patients. “Most of the time…they are being led by the ear of their parents,” she began, “I’m all for patient choice, but there’s also no cure for stupid…We support teenagers and then there are times when we support parents, when the teenager can’t make good decisions for themselves.”

Another clinician implied that patients’ concerns about hormonal contraception are irrational, citing “ethic components” as the primary cause. “It’s most frustrating when I hear, ‘I don’t want any hormones in me or anything foreign in me.’ [That is] the hardest part, because to me, I'm thinking, ‘Well, it's the same hormones that you have in your body circulating anyway. It's nothing,’… I think some people have their mind made up already when you start counseling them, and it's sometimes not worth it to…push through that just for the sake of getting your point across, because I think sometimes there's ethnic components to it.”

This clinician is essentially dismissing BIPOC patients’ concerns as “irrational.” Although contraceptive preferences do differ across racial and ethnic groups, the clinician’s attitude that “it’s nothing” to use hormonal contraception suggests a lack of understanding in regard to structural factors that may influence BIPOC patients.

When counseling patients who express a lack of trust in the health care system, 1 respondent fails to respectfully engage them. Her solution was to say, “I use this method, and [so do] 80% of my female ob-gyn friends who have all of the information and access about all contraceptive methods. [They] choose an IUD.” Her response is dismissive, implying that her patient’s concerns are unjustified and invalid.

The study indicates that clinicians may not consider patients’ refusal to use contraceptive methods like LARC as an assertion of agency and autonomy. Their counseling approaches did not assess or respect patients’ needs, preferences, safety concerns, or suspicions. As for counseling adolescent patients, many clinicians reinforced an imbalance of power and used their status as adults and medical experts to promote contraceptive use. 

“While person-centered contraceptive counseling and shared decision-making has received significant attention, fostering clinicians’ structural competency is an important step medicine could systematically undertake to rectify provider bias,” the authors wrote.

“Contraceptive counseling informed by structural competency—that centers patients’ preferences and autonomy, regardless of clinicians’ beliefs about patients’ ‘best interests’—is better situated to realize the aims of reproductive justice for all pregnancy-capable people,” they concluded.

Mann ES, Chen AM, Johnson CL. Doctor Knows Best? Provider Bias in the Context of Contraceptive Counseling in the United States. 

. Published online December 2021. doi:10.1016/j.contraception.2021.11.009

Poll

Provider bias—stereotyped and prejudiced assumptions about patients and their “best interests”—can unintentionally harm your patients.

Poll: Does your practice or institution offer implicit bias training? 

Hysterosalpingography for boomers to zoomers

Although the hysterosalpingogram (HSG) is the oldest special radiologic procedure, first performed over 110 years ago, it remains an essential part of the evaluation of the infertile couple.

2019 ASCCP guidelines: Pearls for practitioners

Consensus group discussion resulted in a shift from results-based to risk-based management for cervical cancer screening.

The impact of hospitalization from COVID-19, especially severe disease, has greatly impacted our health care system—particularly the nursing staff.

Designing your patient’s prenatal care “PATH"

Recommendations for maternity care professionals based on MiPATH.


Anger, resentment and the unvaccinated COVID-19 patient

Do no harm, even though your patient might.

What's coming to Contemporary OB/GYN® this week.

This week on Contemporary OB/GYN®: Jan. 10 to Jan. 14

 on menstrual health have led to much vaccine hesitancy. While its effects weren’t studied in the initial Pfizer/BioNTech, Moderna, and Johnson & Johnson clinical trials, recent research delivers reassuring results.

A retrospective cohort analysis found that slight, temporary changes in menstrual cycles may occur after COVID-19 vaccination but return to normal after 2 postvaccine cycles.

Investigators conducted a retrospective cohort analysis of nearly 4000 vaccinated and unvaccinated women, examining 6 cycles of menstrual data using the US Food and Drug Administration-approved fertility app 

Data were used from women in the United States aged 18 to 45. All women reported normal cycle lengths (24 to 38 days), and investigators included data of the vaccinated group for 3 consecutive cycles before the first vaccine dose, followed by vaccine dose cycles (cycles 4-6). Data for the unvaccinated group included 6 cycles in a similar period. They included women in the United States aged 18 to 45 with normal cycle lengths of 24 to 38 days over the course of 3 consecutive cycles.

Of the 3959 women, 2403 were vaccinated and 1556 were not. Most of the vaccinated women received the Pfizer/BioNTech vaccine (55%), followed by Moderna (35%) and Johnson & Johnson/Janssen (7%). 

After adjusting for confounders, investigators reported that all women experienced small variations in cycle length, regardless of vaccination status. As for the vaccinated group, the difference in cycle length was less than 1 day when compared with the unvaccinated group. A small group of women who received both vaccine doses in the same cycle had their period for an average of 2 days longer than the unvaccinated group, but this alteration diminished after 2 postvaccine cycles. 

Investigators found no change in menses length between or within the 2 groups.

These results are useful for ob-gyns because, even though a 1-day change is not clinically significant, a cycle change of any kind may cause concern or raise hopes of patients avoiding or planning for pregnancy.

Edelman A, Boniface ER, Benhar E, et al. Association between menstrual cycle length and coronavirus disease 2019 (COVID-19) vaccination: a U.S. cohort. 

 Published online January 5, 2022. doi:10.1097/AOG.0000000000004695

A study published January 6, 2022 showed that COVID-19 vaccinations may temporarily cause changes to the timing of menstruation. 